Johnson & Johnson's Ethicon Biosurgery business plans to add 270 jobs to its manufacturing operation in Ireland.
Johnson & Johnson (NYSE:JNJ) plans to add 270 jobs to its Ethicon Biosurgery operation in Ireland, according to the Irish Times.
Medtronic details its humanitarian sales to Syria, Cuba and Sudan to the U.S. Securities & Exchange Commission.
The U.S. Securities & Exchange Commission closed its review of Medtronic's sales to strife-torn Syria and Sudan and to Cuba, which the medical device company said are made on a humanitarian basis and amount to a small fraction of its total business.
The SEC asked Medtronic in January to explain its business contacts in the 3 nations, which are flagged as state sponsors of terrorism and are subject to U.S. economic sanctions and assets controls.
Zynex lands approval to market its NexWave and NeuroMove devices in Russia, adding to the range of approvals both devices now have worldwide.
Zynex (OTC:ZYXI) obtained marketing clearance in Russia for both its NeuroMove and NexWave devices.
HeartSine Technologies secured a multi-million dollar deal with the Singapore Ministry of Defence to equip every military camp with automated external defibrillators.
HeartSine Technologies touted some good news, landing a deal with the Singapore Ministry of Defence for the company's automated external defibrillators.
HeartSine's AEDs were selected after a competitive process where many different manufacturers submitted bids for the contract. HeartSine was selected for its compact size, light weight and its CPR Advisor, the company said.